Success for ex-Pfizer scientists with Novartis dermatology sale
Interesting News from Pharmaphorum
This article in Pharmaphorum makes interesting reading:
Success for ex-Pfizer scientists with Novartis dermatology sale
“Novartis is to acquire Ziarco, a privately held UK company focused on developing new treatments in dermatology.
Mike Yeadon, Wai (Steve) Liu, Lynn Purkins, and Arif Shivji were all working in Pfizer's allergy and respiratory research when Pfizer announced plans to close R&D operations in Kent. They decided to build a new research-based company around promising several drug candidates which Pfizer would have otherwise shelved. Set up in October 2012 with financial backing from Pfizer's venture capital unit and others, Ziarco is based on Pfizer's old research site, now reborn as a science business cluster, Discovery Park.
Novartis says the acquisition will augment its dermatology portfolio and pipeline.”
It gets even more interesting
This article in Fierce Pharma reveals more:
Novartis dumps Ziarco eczema drug, taking $485M hit
“Novartis cut …